Press Releases Archives - Philogen Spa

05 giugno 2023 – Aggiornamento sul programma di acquisto di azioni proprie

Jun 5, 2023 | 2023, Investors, Press Releases

More details

Philogen Announces Clinical Trial Collaboration with MSD

Jun 1, 2023 | 2023, Press Releases, Scientific

Nidlegy™_CTCSA_Merck_Press_Release_ENG

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand (Price Sensitive)

May 30, 2023 | 2023, Investors, Press Releases

More details

Sun Pharma e Philogen stipulano un Accordo di commercializzazione, Licenza e Fornitura in esclusiva per il prodotto innovativo Nidlegy™ in Europa, Australia e Nuova Zelanda (Price Sensitive)

May 30, 2023 | 2023, Investors, Press Releases

More details

29 maggio 2023 – Aggiornamento sul programma di acquisto di azioni proprie

May 29, 2023 | 2023, Investors, Press Releases

More details

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

May 26, 2023 | 2023, Press Releases, Scientific

230524_Philogen_STM_Press_Release

« Older Entries